JANUX THERAPEUTICS INC's ticker is JANX and the CUSIP is 47103J105. A total of 45 filers reported holding JANUX THERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,497,978 | -17.8% | 148,609 | -3.1% | 0.00% | – |
| Q2 2023 | $1,821,286 | +16.2% | 153,436 | +18.3% | 0.00% | – |
| Q1 2023 | $1,568,000 | +114687.7% | 129,657 | +24.9% | 0.00% | – |
| Q4 2022 | $1,366 | -99.9% | 103,783 | -1.2% | 0.00% | – |
| Q3 2022 | $1,422,000 | +12.5% | 105,053 | +1.5% | 0.00% | – |
| Q2 2022 | $1,264,000 | +393.8% | 103,478 | +477.3% | 0.00% | – |
| Q1 2022 | $256,000 | -2.3% | 17,926 | +34.9% | 0.00% | – |
| Q4 2021 | $262,000 | +87.1% | 13,288 | +105.3% | 0.00% | – |
| Q3 2021 | $140,000 | +775.0% | 6,474 | +902.2% | 0.00% | – |
| Q2 2021 | $16,000 | – | 646 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RA Capital Management | 8,670,644 | $105,869,000 | 2.82% |
| 5AM Venture Management, LLC | 446,266 | $5,449,000 | 1.35% |
| Samsara BioCapital, LLC | 360,414 | $4,401,000 | 1.17% |
| BVF INC/IL | 1,470,334 | $17,953,000 | 0.87% |
| Orbimed Advisors | 2,836,386 | $34,632,000 | 0.63% |
| EcoR1 Capital, LLC | 1,421,319 | $17,354,000 | 0.60% |
| Parkwood LLC | 33,750 | $412,000 | 0.07% |
| Woodline Partners LP | 286,383 | $3,497,000 | 0.05% |
| Cerity Partners LLC | 150,933 | $1,843,000 | 0.02% |
| JANUS HENDERSON GROUP PLC | 2,127,797 | $25,966,000 | 0.02% |